|
| Workforce | Rates (%) | p-value |
| SEX |
| ||
| Female | 62 | 35.6 | <0.001 |
| Male | 112 | 64.4 | |
| TREATMENT |
| ||
| Tenofovir | 12 | 24.0 | 0.003 |
| Traditional | 3 | 6.0 | |
| No treatment | 11 | 22.0 | |
| Not specified | 24 | 48.0 | |
| Holy subjects (Witnesses) | 124 | 71.26 | |